Context: Genetic evaluation has been recognized as an important tool to elucidate the causes of growth disorders.
Conclusion:
Our study demonstrated the association of pathogenic variants in IHH with short stature with nonspecific skeletal abnormalities and established a frequent cause of growth disorder, with a preliminary good response to rhGH. (J Clin Endocrinol Metab 103: [604] [605] [606] [607] [608] [609] [610] [611] [612] [613] [614] 2018) M ost apparently healthy children with short stature are classified as having idiopathic short stature (ISS). The conventional evaluation based on clinical findings complemented by laboratory and image examinations is unable to identify the cause of growth impairment observed in these children. Variation in human height is mostly explained by heritable factors; thus, genetic evaluation could elucidate the causes for growth disorders (1) . Common polymorphisms are associated with height in healthy individuals, with a small effect size per locus (2) . Alternatively, there is evidence that rare genetic variants are involved with larger effects on stature (3-5). The candidate gene approach has identified defects in a few genes associated with growth impairment observed in children classified as ISS (6) . Recently, several whole-exome sequencing (WES) studies have reported gene defects responsible for distinct forms of short stature, including genes expressed in growth plate (7) . Heterozygous mutations in ACAN have been identified in families with ISS with accelerated bone maturation (8, 9 ). An FBN1 mutation was identified in two patients with severe short stature and mild form of acromicric dysplasia (10) . Finally, heterozygous mutations in NPPC were recently associated with autosomal-dominant short stature and small hands phenotype (11) . Hence, WES is a potent tool to screen for candidate genes, identify associations between genes and the phenotype, and broaden the phenotypic spectrum of growth disorders associated with a known gene.
In the current study, we first investigated families with autosomal-dominant short stature through WES. This approach allowed us to identify three families with pathogenic variants in the Indian hedgehog gene [IHH, Mendelian Inheritance in Man (MIM) 600726]. This gene codifies an important paracrine regulator of endochondral ossification. Heterozygous mutations in IHH are recognized as the cause of brachydactyly type A1 (BDA1; MIM 112500) (12) . Because our patients with heterozygous IHH variants did not present classic features of this skeletal dysplasia, we have expanded the investigation of IHH defects in a large cohort of patients with ISS and patients with mild skeletal dysplasia. Our results have extended the known phenotype of IHH defects and revealed that heterozygous IHH mutations are a fairly frequent cause of short stature with nonspecific skeletal abnormalities (MIM 616255). Additionally, we have observed a good short response to recombinant human growth hormone (rhGH) in affected patients under therapy.
Patients and Methods

Patients
The respective local ethics committees approved the studies, and the patients or guardians gave their written informed consent. WES was performed on 17 independent Brazilian families with autosomal-dominant ISS as part of an exome sequencing project of patients with growth disorders. All probands fulfilled the following diagnostic criteria: normal birth weight for gestational age, height standard deviation score (SDS) # 22, unremarkable medical history, and absence of abnormal findings on clinical examination or in laboratory tests that could account for short stature. A second Brazilian cohort of children with short stature of unknown cause [111 with ISS and 19 born small for gestational age (SGA) but with family history of short stature] had IHH screened by Sanger sequencing (n = 81) or targeted gene sequencing panel (n = 49). Clinical characteristics of the Brazilian cohort are shown in Supplemental Table 1 . Additionally, a Spanish cohort of shortstature patients referred for unspecific brachydactyly (n = 60) or mild skeletal dysplasia (n = 100) was evaluated with a skeletal dysplasia-targeted gene sequencing panel that included IHH. In all enrolled patients and their relatives, genomic DNA was obtained from peripheral blood leukocytes by using standard techniques. A cohort of 609 Brazilian elderly adults (http://abraom.ib.usp.br/), representative of the healthy population, was analyzed with WES and was used to compare the frequency of IHH variants in the Brazilian healthy population.
Exome sequencing
We performed WES in the probands and their first-degree relatives according to previously published protocols (10, 13) . Briefly, the libraries were constructed with the SureSelect Target Enrichment System (Agilent Technologies, Santa Clara, CA) according to the manufacturer's instructions. The sequences were generated in the HiSEQ 2500 platform (Illumina, San Diego, CA) running on paired-end mode. Reads were aligned to the GRCh37/hg19 assembly of the human genome with the Burrows-Wheeler Alignment (BWA-mem) aligner. Variant calling included single-nucleotide variants and small insertions and deletions and was performed with Freebayes. The resulting data (in variant call format) were annotated with ANNOVAR. The median coverage of the target bases was 1143, with 97% of the target bases having $103 coverage.
Targeted sequencing
Patients were analyzed by a customized panel of targeted sequencing, which included IHH [for Brazilian patients: Agilent SureSelect assay (Agilent Technologies); for Spanish patients: NimbleGen SeqCap EZ capture (Roche, Pleasanton, CA)]. Sequencing was performed on an Illumina MiSeq or NextSeq platform in paired-end mode. Inhouse bioinformatic analysis was performed. The sequences were aligned to the reference human assembly (GRCh37/hg19). The median coverage of the target bases was 4093 and 2153, with 95% and 94.1% of the target bases being covered $203 for Brazilian and Spanish patients, respectively.
Data analysis
The exome and the targeted panel sequencing data were screened for rare variants (minor allele frequency , 0.1% in public and in-house databases) located in exonic regions and consensus splice site sequences. Subsequently, our variant filtration prioritized genes on the basis of their potential to be pathogenic: loss-of-function variants and variants predicted to be pathogenic by multiple in silico programs. For variants identified by WES, we selected variants that fitted an autosomal-dominant model in the selected families (Supplemental Figs. 1-3 ). The sequencing reads carrying candidate variants were inspected visually using the Integrative Genomics Viewer (Broad Institute, Cambridge, MA).
Sanger sequencing
All putative pathogenic variants observed by exome and targeted panel sequencing as well as segregation analysis in the families were validated and genotyped by Sanger sequencing. The primers for IHH candidate gene screening were designed to amplify all exons and exon-intron boundaries of the NM_002181.3 transcript (primer sequences and amplification protocols are available upon request). Polymerase chain reaction products were bidirectionally sequenced and analyzed in an ABI 3100/3700XL sequencer (Applied Biosystems, Foster City, CA).
Pathogenicity analysis of identified variants
The pathogenicity of the variants identified during genetic analysis was classified according to the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) guidelines (13) . To support the interpretation of familial cosegregation, a mathematical quantitative criterion was added to the ACMG/AMP guidelines to allow a statistical quantification of familial aggregation data (14) . Population data criteria were evaluated by using two public genomic databases: Genome Aggregation Database (gnomAD: http://gnomad.broadinstitute.org/) and Brazilian genomic variants (ABraOM: http://abraom.ib.usp.br/). Several different computational tools were used to obtain predictive data of each variant (Supplemental Table 2 ). Because the crystal structure of the N-terminal domain of human IHH had been resolved, the potential impact of the mutations located in this region (Table 1) was further evaluated by molecular simulations carried out with the human IHH molecular model and its mutated versions (Supplemental Methods).
To provide additional genetic evidence of the association of IHH with short-stature phenotype with nonspecific skeletal findings (15), we performed aggregate variant analyses comparing allele frequencies between our cohorts of patients and public databases (gnomAD and ABraOM). In these databases, we selected variants with similar characteristics of the IHH variants observed in our cohort of short stature patients: rare variants (minor allele frequency , 0.01) with loss-of-function effect (stop gain, frameshift, or consensus splicing site variants) or rare nonsynonymous variants predicted to be pathogenic by at least four in silico tools (PROVEAN, SIFT, PolyPhen-2, and Mutation Assessor). Allele frequency differences between groups were analyzed by x 2 test, and statistical significance was set at P , 0.05. Statistical analyses were performed by using the SIGMAstat statistical software package (Windows version 4.0; SPSS Inc., San Rafael, CA).
Results
Genetic analysis
Three different heterozygous IHH variants were identified in 3 of 17 families with ISS individuals analyzed through WES ( Fig. 1A-1C ; Supplemental Figs. 1-3). Because the affected individuals did not present specific signs of a skeletal dysplasia (including BDA1), we screened 130 children with short stature of unknown cause for rare variants in IHH. In this group, another two heterozygous IHH variants were identified ( Fig. 1D and 1E ). Among a cohort of Spanish patients with short stature and mild skeletal dysplasia or brachydactyly (n = 160), five additional heterozygous IHH variants were identified by targeted sequencing (Fig. 1F-1J ). Thus, a total of 10 heterozygous IHH variants were identified, 2 frameshift mutations resulting in the premature termination of the protein, and 8 missense variants ( (Fig. 1) . One variant was de novo (paternity and maternity confirmed). Thus, after applying the ACMG-AMP guidelines, four variants were classified as pathogenic and six as likely pathogenic (Table 1) . Primary sequence analyses showed that all IHH-mutated amino acid residues are extremely conserved among nonredundant homologous and related sequences. Although some hydrogen bonds were locally disrupted near the mutated amino acid residues, in general, the presence of the mutations provided more molecular contacts for the whole molecules ( Supplemental Fig. 4 ). In addition, results of the IHH molecular simulations revealed that IHH models bearing N-terminal mutations presented a smaller mean potential energy compared with that of the native molecules (Supplemental Table 3 ; Supplemental Fig. 5) . Conversely, except for the IHH Glu58Lys and Arg149His molecules, the binding energies of the atoms Zn412, Ca413 and Ca414 to all others mutated molecules are greater than that of the wild type one (Supplemental Table 3 ).
The allele frequency of rare IHH variants predicted to be deleterious found in both cohort of patients with short 
Clinical phenotypes
The phenotypic characteristics of the probands and other children with heterozygous IHH variants are shown in Table 3 . Four of the 12 Brazilian children were born SGA regarding birth length, and the other 8 had a birth length SDS in the lower part of the normal range (mean birth length, 21.4 6 0.09 SDS; range, 22.7 to 20.1 SDS). The mean height SDS of the Brazilian children was 22.6 6 0.9 (range, 24.3 to 20.8 SDS). The affected patient (AIII.9) with a height SDS of 20.8 (Fig.1A) was a 14.6-year-old boy with advanced bone age (16.5 years), and his adult height SDS is 21.9. Most affected Brazilian children (n = 8/12) presented mild disproportionate short stature [mean sitting height to height ratio (SH:H) SDS, 2.4 6 1.2; range, 0.3 to 3.6]. Most affected children had mild delayed bone age, but we observed two of them with advanced bone age (Table 3 individuals AIII.6 and AIII.9). Abnormal hand radiographs were observed in 6 of 12 Brazilian children. Two children presented only shortening of the middle phalanx of the fifth finger. Other radiological hand findings include varying degrees of shortening of the middle phalanx of the second and fifth fingers with cone-shaped epiphyses ( Fig. 2A; Supplemental Fig. 7 ). Foot radiographs of patients with heterozygous IHH mutations showed a recurrent shortening of the distal phalanx of the hallux. Other radiological findings observed in feet were cone-shaped epiphyses of proximal phalanges of the second, third, fourth, and fifth toes ( Fig. 2B;  Supplemental Fig. 8 ).
All five Spanish cases were detected in a cohort of patients with mild skeletal dysplasia (3/100) or suspected to have brachydactyly (2/60). Low birth length (22.9 SDS) was observed in one patient (GII.1). The height SDS of Spanish children ranged from 24.0 to 22.6 SDS (mean, 23.2 6 0.6 SDS). SH:H SDS values were in the upper part of the normal range (1.8 and 1.9 SDS) in two of three available probands. Patient JII.1 had a severe delay (23.8 years) in bone age with respect to chronological age. All five patients had mild abnormal skeletal surveys, typically shortening of middle phalanx of the second and fifth fingers (Supplemental Fig. 7) .
A total of 14 adult individuals heterozygous for IHH variants could be assessed (10 Brazilian and 4 Spanish). Their mean height SDS was 23.061.1 (range, 24.3 to 21.7). Eight of nine affected adult individuals available have altered body proportion (SH:H SDS ranged from 2.0 to 4.2) (Supplemental Table 4 ).
Growth response to rhGH treatment
Five patients, all from the Brazilian cohort, with heterozygous IHH variants have been treated with rhGH therapy (50 mg/kg/d) ( Table 4 ). The onset of treatment was prepuberty in all of them. One girl had started puberty during the first year of rhGH treatment (patient CII.2). After exclusion of this patient from first-year growth response, the four remaining patients had a mean improvement in height SDS of 0.6 (range, 0.46 to 0.79) and their height velocity ranged from 8.0 to 10.8 cm/y.
Discussion
Longitudinal bone growth is essential to determine adult body height and depends on the growth plate chondrogenesis, a complex process regulated by endocrine and paracrine factors. Over the past years, mutations in different genes involved in the growth plate have been In the current study, we identified heterozygous IHH mutations in 5 of 147 children initially classified as ISS. Additionally, another 5 heterozygous IHH mutations were identified among short stature patients with subtle signs of a skeletal dysplasia (3/100) or with mild brachydactyly (2/60). According to ACMG-AMP criteria (13) , the identified IHH variants were classified as pathogenic or likely pathogenic (Table 1) .
Along with IHH, Hedgehog (Hh) family proteins include other two Hh homologs with high level of sequence conservation: Sonic Hh (SHH) and Desert Hh, essential for the nervous system and testis development, respectively (19) . Hh proteins are synthesized in the endoplasmic reticulum as a precursor that undergoes an autocatalytic process to yield the N-terminal domain, which has biological signaling activities (20) . Hh action is mediated through Patched and Smoothened receptors and is positively regulated by cell adhesion moleculerelated, downregulated by oncogenes (CDO) and brother of CDO in a calcium-dependent binding mode (19) . IHH is expressed in the prehypertrophic chondrocytes of cartilage and coordinates proliferation and differentiation of chondrocytes during endochondral bone development (21) . Homozygous IHH mutations cause acrocapitofemoral dysplasia (MIM 607778), a disorder characterized by severe disproportionate short stature with cone-shaped epiphyses in hands and hips (22) . In addition, heterozygous mutations in IHH cause BDA1 (MIM 112500). BDA1 is characterized by a marked shortening of the middle phalanges, which are frequently rudimentary or fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are also short (12) . Interestingly, short stature was not consistently demonstrated in patients with BDA1 (12, 23) .
The variants identified in the current study were located throughout the IHH, including two frameshift mutations and eight missense mutations. These findings are in contrast with previous variants associated with BDA1, which were all missense and restricted to the central region of the N-terminal active fragment of IHH Birth length and height SDS are according to population curves.
Abbreviations: F, female; M, male; NA, data not available. a During follow-up, the patient had a growth velocity of 0.6 cm/y, and his height SDS for adult age is 21.9.
(24) (Supplemental Fig. 9 ). Similar to our findings, variants in SHH associated to holoprosencephaly (missense, nonsense, or frameshift) are located throughout the gene (25) . In addition, after single-amino acid code alignment of IHH and SHH, we observed that two of the IHH mutations identified in our patients (p.Glu58Lys and p.Arg149His) are located in the identical residues of pathogenic SHH mutations (p.Glu53Lys and p.Arg144Pro, respectively) (26) . The results of the structural analyses and molecular mechanics simulations experiments based on the IHH molecular structure showed that all mutations located at N-terminal domain could affect the structure and, therefore, the biological function of the molecule. The presence of these mutations determines a smaller total mean potential energy that is associated with a more stable molecule, affecting the calcium and zinc cofactor-binding energy (Supplemental Table 3 ). A greater calcium-binding energies observed in four mutated IHH molecules (p.Glu58Lys, p.Val178Leu, p.Val178Met, and p.Trp177Cys) could affect the interaction to binding partners CDO and brother of CDO, a mechanism already described to IHH mutations associated to BDA1 (19) . It is a challenge to determine the functional impact of variants located in the C-terminal domain of Hh proteins. Nevertheless, one study found no difference in phenotype severity between individuals with holoprosencephaly caused by SHH mutations located in the N-or C-terminal domains (27) . It is postulated that C-terminal variants could impair the preprotein maturation and autocleavage process (26) . Further studies are necessary to elucidate molecular mechanisms of IHH variants responsible for nonsyndromic short stature.
We provide several lines of genetic evidence that the identified IHH variants are associated with short stature with nonspecific skeletal abnormalities (15) . First, at each case level, we demonstrated in several families a segregation with growth impairment phenotype in a dominant inheritance pattern (Fig. 1) . Additionally, a de novo variant (both paternity and maternity confirmed) was identified in a patient with short stature and normal stature parents (Fig. 1E) . Second, we provide statistical evidence that rare IHH variants are enriched in the two analyzed cohorts of short-stature patients in comparison with public databases that involve a large number of individuals not selected by stature (Table 2 ; Supplemental Fig. 6 ).
Patients described in the current study typically manifest mild disproportional short stature. It seems that disproportionality has become more pronounced over the years during childhood. Four probands were born SGA regarding birth length. Intrauterine growth impairment with normal birth weight, especially in children with familial short stature, may suggest defects in genes that play a role in bone elongation. There is a variable phenotype considering the severity of short stature and radiological findings, even among individuals within the same family. The most recurrent radiological finding observed in our patients was varying degrees of shortening of the middle phalanx of the fifth finger, a defining feature of brachymesophalangia V (BMP-V) (28) . BMP-V is the most common skeletal anomaly of the hand and can be observed alone (clinically known as brachydactyly type A3) or in association to other skeletal abnormalities and developmental syndromes. Epiphyses of the fifth finger may be associated with a susceptibility to a chondrogenesis disorder because they are among the last to be ossified in the hand. BMP-V was observed in 64.3% (9/14) hand radiographs from individuals heterozygous from IHH variants in our cohort, whereas the frequency of BMP-V observed in a population study was 12.1% (165/1360; P , 0.001) (28) .
The response to rhGH therapy could be assessed in five patients heterozygous for IHH variants (Table 4) . We considered the short-term response to rhGH therapy presented by this small group of children to be good. The improvement in height SDS at 1 year of rhGH therapy was similar to or better than that previously reported in two larger studies that evaluated responsiveness to rhGH in children with ISS (0.60 SDS and 0.49 SDS, respectively) (29, 30) . A different study developed criteria based on height velocity targets for first-year responses in ISS children. Those researchers proposed that height velocity below the mean 21 SD on their plots should be considered a "poor" response. None of our patients had a first-year height velocity below the mean 21 standard deviation; two were plotted above the mean and can be considered as good (31) .
In conclusion, our data demonstrate the association of rare pathogenic variants in IHH with short stature with nonspecific skeletal abnormalities (MIM 616255). Given the subtle and low specific clinical and radiological findings observed in our patients, only a broad molecular study allowed this association. Thus, we have expanded the phenotype associated with heterozygous IHH mutations and established a frequent cause of growth disorder, with a preliminary good response to rhGH.
